Downtrend on the daily chart: below its 200-day average, above its 50-day · 50-day below the 200-day · SuperTrend down since Sep 8 · inside the Ichimoku cloud · RSI 60 · MACD above its signal
None of the 29 investors followed here reported a position in 6618.HK in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a 6618.HK trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 14, 2026 | Lau (George)Independent Non-Executive Director | — | 13K | — |
| Apr 6, 2026 | Wu (Ying)Independent Non-Executive Director | — | 8K | — |
| Mar 31, 2026 | Cao (Dong)Chief Executive Officer | — | 19.7K | — |
| Mar 31, 2026 | Lau (George)Independent Non-Executive Director | Sale at price 6.23 per share. | 3K | $18.69K |
| Mar 30, 2026 | Zhang (Jiyu)Independent Non-Executive Director | Sale at price 6.06 per share. | 2.8K | $17.22K |
| Mar 29, 2026 | Zhang (Jiyu)Independent Non-Executive Director | — | 9.2K | — |
| Dec 31, 2025 | Cao (Dong)Chief Executive Officer | — | 13.1K | — |
| Nov 26, 2025 | Chen (Xingyao)Independent Non-Executive Director | — | 7.2K | — |
| Nov 26, 2025 | Li (Ling)Independent Non-Executive Director | — | 7.2K | — |
| Oct 14, 2025 | Liu (Qiangdong Richard)Chairman of the Board | — | 8.84M | — |
| Oct 12, 2025 | Lau (George)Independent Non-Executive Director | Sale at price 7.84 per share. | 3K | $23.52K |
| Sep 17, 2025 | Chen (Xingyao)Independent Non-Executive Director | Sale at price 8.69 per share. | 12.8K | $111.25K |
| Aug 20, 2025 | Jin (Enlin Cpa)Chief Executive Officer | Sale at price 8.29 per share. | 158.8K | $1.32M |
| Aug 19, 2025 | Jin (Enlin Cpa)Chief Executive Officer | Sale at price 8.11 per share. | 271.2K | $2.20M |
| Aug 14, 2025 | Lau (George)Independent Non-Executive Director | — | 13K | — |
| Jul 1, 2025 | Jin (Enlin Cpa)Chief Executive Officer | Sale at price 5.41 per share. | 9.2K | $49.64K |
| Jun 30, 2025 | Jin (Enlin Cpa)Chief Executive Officer | — | 20K | — |
| Apr 9, 2025 | Wu (Ying)Independent Non-Executive Director | — | 6.8K | — |
| Apr 2, 2025 | Jin (Enlin Cpa)Chief Executive Officer | Sale at price 4.24 per share. | 42.1K | $178.44K |
| Mar 31, 2025 | Jin (Enlin Cpa)Chief Executive Officer | — | 104.8K | — |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 13.9 | -10.3 | -17.1 | -3.6 | -15.3 | -14.5 | 20.0 | -7.4 | -1.4 | 3.2 | −33.1% | ||
| 2025 | 13.1 | 5.8 | -1.9 | 11.9 | 8.2 | 7.1 | 17.0 | 24.9 | 5.9 | -8.7 | 0.7 | -9.1 | +96.6% |
| 2024 | -34.5 | 16.4 | -7.0 | -2.0 | -3.7 | -18.7 | 2.4 | 8.3 | 48.6 | -20.6 | 2.0 | -0.4 | −27.7% |
| 2023 | -9.2 | -15.5 | 6.7 | -3.7 | -14.2 | 2.5 | 13.9 | -24.9 | -4.0 | -12.4 | 4.8 | 5.0 | −45.2% |
| 2022 | 0.9 | -7.1 | -16.9 | 5.1 | -1.2 | 23.2 | -3.3 | -8.2 | -17.5 | -4.5 | 58.2 | 4.8 | +15.5% |
| 2021 | 2.4 | -7.1 | -21.4 | 8.5 | -14.6 | 7.7 | -25.0 | -13.4 | 3.9 | -8.3 | -1.3 | -9.1 | −58.5% |
| 2020 | — |
JD Health International Inc., an investment holding company, engages in the operation of an online healthcare platform in the People's Republic of China. It provides online medical consultation, hospital or doctor referral, health check-ups, genetic testing, and beauty care services, as well as internet healthcare, health management, intelligent healthcare, advertising, and technical services. The company also offers home care services, including wound care, blood tests and diagnostics, post-operative care, and medical escort; online medical insurance payment services; and smart healthcare and digital health solutions. In addition, it provides online marketing services to advertisers; and online shopping and hospital services. Further, the company offers smart monitoring and respiratory therapy devices; senior-oriented medical devices; home medical device set-up and support services, including blood glucose meters and oxygen generators; and rapid testing products. Additionally, it provides traditional Chinese medicine (TCM) wellness and professional orthopedic services, as well as operates offline examination and polyclinic centers that offers convenient and professional healthcare services. The company offers pharmaceutical and healthcare products through direct sales, and online marketplace and on-demand retail businesses. It serves pharmaceutical and healthcare product companies. JD Health International Inc. was founded in 2014 and is headquartered in Beijing, the People's Republic of China. JD Health International Inc. is a subsidiary of JD Jiankang Limited.
Buy / hold / sell counts
No recent headlines.